No profile data available.
Prestige Consumer Healthcare Inc. (PBH) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Tarrytown, United States, with about 890 full-time employees.
It reported revenue of $1.09 billion for fiscal year 2026, down 4.3% from fiscal year 2025, and net income of $190.30 million. In Q1 2027 (the quarter ended June 30, 2026) revenue was $265.71 million, up 6.5% from a year before. Its largest business segment, North American Over-The-Counter Healthcare, brought in 84% of segment revenue in fiscal year 2026; United States was the largest region with 78%. Its market capitalization was $2.28 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Prestige Consumer Healthcare reported $1.09 billion in revenue for fiscal year 2026, down 4.3% from $1.14 billion in fiscal year 2025. In Q1 2027 revenue was $265.71 million.
North American Over-The-Counter Healthcare, with $917.38 million or 84% of segment revenue in fiscal year 2026. Next: International Over-The-Counter Healthcare (16%).
United States: 78% of revenue by region in fiscal year 2026, followed by Rest of World (22%).
$2.28 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Terns Pharmaceuticals, Inc. (TERN), Adma Biologics, Inc. (ADMA), Nurix Therapeutics, Inc. (NRIX), Bausch Health Companies Inc. (BHC).